Severity and impairment of allergic rhinitis in patients consulting in primary care
- PMID: 16387600
- DOI: 10.1016/j.jaci.2005.09.047
Severity and impairment of allergic rhinitis in patients consulting in primary care
Abstract
Background: Allergic rhinitis is a disease impairing quality of life, sleep, and work. A new classification for allergic rhinitis, Allergic Rhinitis and its Impact on Asthma (ARIA), has recently been proposed.
Objective: To study the effect of allergic rhinitis using ARIA definitions to determine severity and duration.
Methods: A total of 3052 patients consulting general practitioners for allergic rhinitis were studied. Patients were classified according to the 4 classes of ARIA. In all patients, quality of life (Rhinoconjunctivitis Quality-of-Life Questionnaire), sleep (Jenkins questionnaire), and work performance (Allergy-Specific Work Productivity and Activity Impairment questionnaire) were assessed.
Results: Mild intermittent rhinitis was diagnosed in 11% of the patients, mild persistent rhinitis in 8%, moderate/severe intermittent rhinitis in 35%, and moderate/severe persistent rhinitis in 46%. The severity of rhinitis has more of an effect on quality of life, sleep, daily activities, and work performance than the duration of rhinitis. In moderate/severe rhinitis, more than 80% of patients report impaired activities, as opposed to only 40% with mild rhinitis.
Conclusion: It seems that the term moderate/severe should be replaced by severe. A study in the general population is necessary, however, to assess the prevalence of the 4 ARIA classes of allergic rhinitis, especially in patients who are not consulting physicians for their symptoms.
Similar articles
-
Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort study.Rhinology. 2010 Jun;48(2):201-5. doi: 10.4193/Rhin09.099. Rhinology. 2010. PMID: 20502761
-
Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group.Clin Exp Allergy. 2005 Jun;35(6):728-32. doi: 10.1111/j.1365-2222.2005.02274.x. Clin Exp Allergy. 2005. PMID: 15969662
-
A survey of the burden of allergic rhinitis in Europe.Allergy. 2007;62 Suppl 85:17-25. doi: 10.1111/j.1398-9995.2007.01549.x. Allergy. 2007. PMID: 17927674
-
Assessing outcomes from the sleep disturbance associated with rhinitis.Curr Opin Allergy Clin Immunol. 2007 Jun;7(3):249-56. doi: 10.1097/ACI.0b013e3280f3c09f. Curr Opin Allergy Clin Immunol. 2007. PMID: 17489043 Review.
-
Management of allergic rhinitis.B-ENT. 2005;Suppl 1:45-62; quiz 63-4. B-ENT. 2005. PMID: 16363267 Review.
Cited by
-
Phenotyping of allergic rhinitis.Curr Allergy Asthma Rep. 2012 Apr;12(2):115-9. doi: 10.1007/s11882-012-0243-x. Curr Allergy Asthma Rep. 2012. PMID: 22274541 Review.
-
A patient-centric analysis to identify key influences in allergic rhinitis management.NPJ Prim Care Respir Med. 2018 Sep 13;28(1):34. doi: 10.1038/s41533-018-0100-z. NPJ Prim Care Respir Med. 2018. PMID: 30213945 Free PMC article.
-
A qualitative investigation of the allergic rhinitis network from the perspective of the patient.NPJ Prim Care Respir Med. 2019 Sep 19;29(1):35. doi: 10.1038/s41533-019-0147-5. NPJ Prim Care Respir Med. 2019. PMID: 31537804 Free PMC article.
-
In response to Letter regarding "Revision adenoidectomy in children: a population-based cohort study in Taiwan".Eur Arch Otorhinolaryngol. 2017 Oct;274(10):3823-3824. doi: 10.1007/s00405-017-4703-8. Epub 2017 Aug 21. Eur Arch Otorhinolaryngol. 2017. PMID: 28828724 No abstract available.
-
Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index - the benefica study.Allergy Asthma Clin Immunol. 2015 Feb 26;11(1):8. doi: 10.1186/s13223-015-0073-1. eCollection 2015. Allergy Asthma Clin Immunol. 2015. PMID: 25741366 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical